2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future

J Wintrich, I Kindermann, C Ukena, S Selejan… - Clinical Research in …, 2020 - Springer
In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction
(HFrEF), therapeutic efforts in the past have failed to improve outcomes in heart failure with …

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) …

JC Nielsen, YJ Lin, MJ de Oliveira Figueiredo… - Ep …, 2020 - academic.oup.com
Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement …

S Tzeis, EP Gerstenfeld, J Kalman, EB Saad… - Europace, 2024 - academic.oup.com
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal

DA Lane, GYH Lip - European Heart Journal Supplements, 2020 - academic.oup.com
Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …

Bone morphogenetic protein 10—a novel biomarker to predict adverse outcomes in patients with atrial fibrillation

E Hennings, S Blum, S Aeschbacher… - Journal of the …, 2023 - Am Heart Assoc
Background Patients with atrial fibrillation (AF) face an increased risk of death and major
adverse cardiovascular events (MACE). We aimed to assess the predictive value of the …

Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction

D Rucker, J Joseph - Current heart failure reports, 2022 - Springer
Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) imposes a
significant burden on society and healthcare. The lack in efficacious therapies is likely due to …

Novel insights into peptide amidation and amidating activity in the human circulation

P Kaufmann, A Bergmann, O Melander - Scientific Reports, 2021 - nature.com
C-terminal α-amidation is the final and essential step in the biosynthesis of several peptide
hormones. Peptidylglycine α-amidating monooxygenase (PAM) is the only known enzyme to …

Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?

O Hahad, PS Wild, JH Prochaska, A Schulz… - Clinical Research in …, 2021 - Springer
Background Environmental noise exposure has been associated with increased
cardiovascular morbidity and mortality. Recently, noise annoyance was shown to induce …

[HTML][HTML] Value of N-terminal pro-brain natriuretic peptide for embolic events risk prediction in patients with atrial fibrillation; a systematic review and meta-analysis

K Ahmadzadeh, A Hajebi, HA Ramawad… - Archives of Academic …, 2023 - ncbi.nlm.nih.gov
Method: Two independent reviewers screened all relevant studies that were retrieved from
the database of Medline, Embase, Scopus, and Web of Science until December 7th, 2021 …